MS4A2 Gene (FcεRIβ)

MS4A2 Gene — FcεRIβ (Membrane Spanning 4-Domains A2)

Overview

The MS4A2 gene (Membrane Spanning 4-Domains A2), also known as FcepsilonRIbeta (beta subunit of the high-affinity IgE receptor), encodes a critical component of the Fc epsilon receptor complex. Located on chromosome 11q12.2, this gene plays essential roles in immunoglobulin E (IgE) signaling and has emerged as a significant genetic risk factor for late-onset Alzheimer's disease (AD)[@hollingworth2011][@sims2017].

The MS4A gene cluster on chromosome 11 contains several genes (MS4A1, MS4A2, MS4A3, MS4A4E, MS4A6A, MS4A7, MS4A8) that have been implicated in AD susceptibility through genome-wide association studies (GWAS). Among these, MS4A2 and its nearby locus MS4A4E have shown consistent associations with AD risk, disease progression, and cerebrospinal fluid (CSF) biomarker levels["@bermingham2018"][@proitsi2012].

<aside class="infobox infobox-gene"> MS4A2 Quick Facts

MS4A2 Gene — FcεRIβ (Membrane Spanning 4-Domains A2)

Overview

The MS4A2 gene (Membrane Spanning 4-Domains A2), also known as FcepsilonRIbeta (beta subunit of the high-affinity IgE receptor), encodes a critical component of the Fc epsilon receptor complex. Located on chromosome 11q12.2, this gene plays essential roles in immunoglobulin E (IgE) signaling and has emerged as a significant genetic risk factor for late-onset Alzheimer's disease (AD)[@hollingworth2011][@sims2017].

The MS4A gene cluster on chromosome 11 contains several genes (MS4A1, MS4A2, MS4A3, MS4A4E, MS4A6A, MS4A7, MS4A8) that have been implicated in AD susceptibility through genome-wide association studies (GWAS). Among these, MS4A2 and its nearby locus MS4A4E have shown consistent associations with AD risk, disease progression, and cerebrospinal fluid (CSF) biomarker levels["@bermingham2018"][@proitsi2012].

<aside class="infobox infobox-gene"> MS4A2 Quick Facts

| Property | Value |
|---------|-------|
| Gene Symbol | MS4A2 |
| Full Name | Membrane Spanning 4-Domains A2 (FcepsilonRIbeta) |
| Chromosome | 11q12.2 |
| NCBI Gene ID | 2538 |
| UniProt ID | Q08431 |
| Ensembl ID | ENSG00000149507 |
| Aliases | FcepsilonRIbeta, MS4A2, FCER1B |
| Protein Length | 245 aa |
| Primary Function | IgE receptor signaling, mast cell/basophil activation |
| Associated Diseases | Alzheimer's disease, atopic dermatitis, allergy |
</aside>

Gene Structure and Expression

Gene Organization

The MS4A2 gene spans approximately 15 kb on chromosome 11q12.2 and consists of 7 exons encoding a 245-amino acid protein. The gene produces multiple alternatively spliced isoforms with cell-type-specific expression patterns. MS4A2 is part of the MS4A gene cluster, which arose from tandem duplication events during evolution, creating a family of structurally related genes[@hollingworth2011].

Tissue Distribution

MS4A2 expression is primarily associated with immune cells:

• Mast cells: Highest expression in tissue mast cells, particularly in skin, lung, and gastrointestinal tract
• Basophils: Significant expression in circulating basophils
• Dendritic cells: Lower expression in certain dendritic cell subsets
• Microglia: Expression in brain microglia, particularly in AD brains[@karch2012][@rosenberg2016]
• Brain: Expression in the CNS, with regional variation

Subcellular Localization

• Plasma membrane: Primary localization as a transmembrane receptor component
• Cytoplasmic vesicles: Internalization and trafficking through endosomal compartments
• Mast cell granules: Association with secretory granules in activated mast cells

Protein Structure and Function

Domain Architecture

The MS4A2 protein (FcεRIβ) contains several functional domains:

FcεRI Complex Assembly

MS4A2/FcεRIβ functions as the beta subunit of the high-affinity IgE receptor complex:

FcεRI Complex = 1α + 1β + 2γ subunits

• FcεRIα: Binds IgE with high affinity (Kd ~ 10^-9 M)
• FcεRIβ: Amplifies signal transduction through its ITAM
• FcεRIγ: Contains ITAM and initiates downstream signaling

Signaling Pathways

Upon antigen-induced IgE cross-linking, FcεRI triggers multiple signaling cascades:

Role in Neurodegeneration

Alzheimer's Disease

MS4A2 genetic variants have been consistently associated with AD risk through GWAS and subsequent validation studies[@hollingworth2011][@sims2017]. The mechanism involves several interconnected pathways:

1. Microglial Activation and Neuroinflammation

MS4A2 is highly expressed in microglia, and genetic variants influence microglial function:

• Pro-inflammatory responses: MS4A2 variants affect cytokine production in response to immune stimuli
• Phagocytic capacity: Altered microglial clearance of amyloid-β plaques
• Disease-associated microglia (DAM): MS4A2 expression is elevated in DAM, a protective microglial response to AD pathology[@cruchaga2013]

2. Amyloid Pathology

MS4A2 affects amyloid processing and plaque formation:

• Amyloid precursor protein (APP) processing: MS4A2 influences APP cleavage by β- and γ-secretases
• Plaque burden: Genetic variants correlate with regional amyloid plaque density
• Amyloid clearance: Microglial phagocytosis of amyloid-β is modulated by MS4A2

3. CSF Biomarkers

MS4A2 genetic variants are associated with cerebrospinal fluid biomarker changes[@proitsi2012][@harbers2021]:

• Tau levels: Association with CSF total tau and phosphorylated tau
• Amyloid-β: Correlation with CSF Aβ42 levels
• Neurofilament light (NfL): Association with neurodegeneration markers

4. Neuroimmune Network

MS4A2 participates in the neuroimmune axis:

• Cytokine modulation: MS4A2 affects production of IL-1β, TNF-α, and other cytokines
• Blood-brain barrier: May influence peripheral immune cell entry into the CNS
• Complement system: Interactions with complement proteins in microglial phagocytosis

Mast Cells and CNS Function

Although traditionally considered peripheral immune cells, mast cells are present in the CNS[@mauch1993][@silverman2000]:

• Brain mast cells: Located in the meninges, perivascular spaces, and specific brain regions
• Blood-brain barrier: Mast cells can influence BBB permeability
• Neuroinflammation: Mast cell activation contributes to neuroinflammatory responses
• Neurodegeneration: Mast cell mediators can affect neuronal survival

Neuroinflammation Mechanisms

MS4A2 contributes to neuroinflammation through multiple mechanisms[@dawson2020][@skaper2014]:

Key Interactions

| Protein/Pathway | Interaction | Functional Consequence |
|-----------------|-------------|----------------------|
| [FCER1G](/genes/fcer1g) | FcεRIγ subunit | Signal transduction |
| IgE | Antibody binding | Receptor activation |
| SYK | Kinase interaction | Signaling cascade initiation |
| MS4A4E | Gene cluster neighbor | Co-expression in microglia |
| MS4A6A | Gene cluster neighbor | AD risk modulation |
| TREM2](/genes/trem2) | Microglial pathway | Synergistic AD risk |
| CD33](/genes/cd33) | Immune receptor | Microglial activation |

Therapeutic Implications

Targeting MS4A2 Pathways

Modulating MS4A2 function could provide therapeutic benefits in AD:

1. Immunomodulatory Approaches

• Anti-IgE therapy: Omalizumab blocks IgE binding to FcεRI
• FcεRI antagonists: Small molecules that prevent receptor activation
• Mast cell stabilizers: Cromolyn, ketotifen reduce mast cell activation

2. Microglial Modulation

• MS4A2 expression modulators: Enhance protective microglial responses
• TREM2-MS4A2 synergy: Combined approaches targeting microglial pathways

3. Anti-inflammatory Strategies

• Cytokine inhibitors: Target downstream inflammatory effects
• Mast cell mediators: Block specific pro-inflammatory molecules

Challenges and Considerations

Clinical Considerations

Biomarkers

Clinical Trials

• Omalizumab in AD: Investigating anti-IgE effects on neuroinflammation
• Mast cell stabilizers: Pilot studies in early AD
• MS4A-targeted interventions: Preclinical development

Research Models and Tools

Experimental Models

• Cell lines: HMC-1 mast cells, RBL-2H3 rat basophilic leukemia cells
• Animal models: FcεRIβ knockout mice, AD mouse models (APP/PS1, 5xFAD)
• iPSC models: Microglia derived from AD patient iPSCs
• Organoid models: Brain organoids with microglia

Antibodies and Reagents

• Anti-MS4A2: Santa Cruz (sc-515013), Abcam (ab187531)
• FcεRIβ detection kits: Flow cytometry, Western blot
• IgE: Various sources for receptor activation studies

Database Resources

• [NCBI Gene - MS4A2](https://www.ncbi.nlm.nih.gov/gene/2538)
• [UniProt - Q08431](https://www.uniprot.org/uniprot/Q08431)
• [Ensembl - MS4A2](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000149507)
• [GWAS Catalog - MS4A2](https://www.ebi.ac.uk/gwas/search?query=MS4A2)

Cross-Links

Related Genes

• [MS4A4E](/genes/ms4a4e) — MS4A gene family, AD risk
• [MS4A6A](/genes/ms4a6a) — MS4A gene family, microglial expression
• [MS4A1](/genes/ms4a1) — CD20, B cell marker
• [TREM2](/genes/trem2) — Microglial AD risk gene
• [CD33](/genes/cd33) — Microglial immune receptor

Related Mechanisms

• [Microglial Activation in AD](/mechanisms/microglial-activation-ad)
• [Neuroinflammation Pathways](/mechanisms/neuroinflammation)
• [Amyloid Clearance Mechanisms](/mechanisms/amyloid-clearance)
• [Neuroimmune Interactions](/mechanisms/neuroimmune-axis)

Related Diseases

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Atopic Dermatitis](/diseases/atopic-dermatitis)
• [Allergic Inflammation](/diseases/allergy)

See Also

• [Genes Index](/genes)
• [Neurodegenerative Disease Mechanisms](/mechanisms)
• [Immunology of Neurodegeneration](/mechanisms/neuroimmunology)
• [Alzheimer's Disease Treatment](/therapeutics/alzheimers-treatment)

References